Validation of the HER2DX genomic test in first-line advanced HER2-positive breast cancer treated with trastuzumab, pertuzumab, and taxane
验证 HER2DX 基因组检测在接受曲妥珠单抗、帕妥珠单抗和紫杉烷一线治疗的 HER2 阳性晚期乳腺癌患者中的应用价值
期刊:NPJ Breast Cancer
影响因子:7.6
doi:10.1038/s41523-026-00909-0
Kubeczko, Marcin; Cobo, Sandra; Sanchez-Bayona, Rodrigo; Pyciński, Bartłomiej; Soberino, Jesús; Chmielik, Ewa; Sanfeliu, Esther; Rey, Maria; Pardo, Francisco; Aguirre, Angela; Castillo, Oleguer; Lesniak, Aleksandra; Oczko-Wojciechowska, Malgorzata; Carcelero, Esther; Adamo, Barbara; Vidal, Maria; Bergamino, Milana; Maues, Julia; Villacampa, Guillermo; Paré, Laia; Villagrasa, Patricia; Ciruelos, Eva; Prat, Aleix; Jarzab, Michal; Brasó-Maristany, Fara
